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Introduction: Endometriosis is a common
gynaecological disease characterised by pain and
subfertility. Randomised controlled trials evaluating
treatments for endometriosis have reported many
different outcomes and outcome measures. This
variation restricts effective data synthesis limiting the
usefulness of research to inform clinical practice. To
address these methodological concerns, we aim to
develop, disseminate and implement a core outcome
set for endometriosis engaging with key stakeholders,
including healthcare professionals, researchers and
women with endometriosis.
Methods and analysis: An international steering
group has been established, including healthcare
professionals, researchers and patient representatives.
Potential outcomes identified from a systematic review
of the literature will be entered into a modified Delphi
method. Key stakeholders will be invited to participate
including healthcare professionals, researchers and
women with endometriosis. Participants will be invited
to score individual outcomes on a nine-point Likert
scale anchored between 1 (not important) and 9
(critical). Repeated reflection and rescoring should
promote whole and individual stakeholder group
converge towards consensus, ‘core’, outcomes. High-
quality outcome measures will be associated with core
outcomes.
Ethics and dissemination: The implementation of a
core outcome set for endometriosis within future
clinical trials, systematic reviews and clinical guidelines
will enhance the availability of comparable data to
facilitate evidence-based patient care. This study was
prospectively registered with Core Outcome Measures
in Effectiveness Trials Initiative; number: 691.
INTRODUCTION
Endometriosis is a chronic inflammatory
disease characterised by lesions of
endometrial-like tissue outside the uterus that
is associated with pelvic pain and/or infertil-
ity.1 It is a common condition affecting
women of reproductive age and may be asso-
ciated with substantially reduced quality of
life.2 To address this considerable health
burden novel treatments are continually
being developed, which require robust evalu-
ation. While significant effort has been paid
to developing randomised controlled trial
methods, the collection and reporting of out-
comes and outcomes measures has been
largely overlooked. The consequence of this
is a plethora of differing outcomes that make
drawing conclusions across a group of studies
difficult and, sometimes, impossible.
We performed a systematic review of ran-
domised trials evaluating treatments for
endometriosis.3 A total of 54 trials reported
164 different outcomes measured by 113 dif-
ferent definitions and instruments. The com-
monest pain outcome, dysmenorrhoea, was
measured by ten different instruments. The
commonest fertility outcome, pregnancy, was
measured by three different definitions. The
lack of consensus regarding the collection
and reporting of outcomes prohibits the
comparison and combination of individual
trial data, limiting the usefulness of research
to inform clinical practice.
The endometriosis research community
has previously engaged with standardising
important aspects of research design. The
Art and Science of Endometriosis meeting,
convened by the National Institutes of
Health, has published recommendations
regarding the standardisation of research
design in several areas including entry cri-
teria and outcome measures for pain symp-
toms.4 The World Endometriosis Research
Foundation Endometriosis Phenome and
Biobanking Harmonization Project (WERF
EPHect) has published tools for the stand-
ardisation of research design in several areas
including clinical, covariate and surgical
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phenotype recording and specimen collection, process-
ing and storage.5–8 Their work continues, involving
global participants from a range of stakeholder groups
including healthcare professionals, researchers, industry
representatives and women with endometriosis, reflect-
ing the enthusiasm of our specialty to work together to
improve research design and clinical care.
The next challenge is to address the unwarranted,
unhelpful and often confusing variation in outcome col-
lection and reporting. The development and use of a
core outcome set would help to address this challenge.
Core outcome sets are well-defined, discriminatory and
feasible outcomes routinely collected and reported in
randomised trials and systematic reviews. They represent
a minimum data set of outcomes selected and priori-
tised by key stakeholders including healthcare profes-
sionals, researchers and women with endometriosis.9
The development and use of a core outcome set does
not enforce harmony at the expense of innovation. The
existence or use of a core outcome set does not imply
that outcomes in an endometriosis trial should be
restricted.9 Rather, there is an expectation that the core
outcomes will be collected and reported, making it
easier for the results of trials to be compared, contrasted
and combined as appropriate; while researchers con-
tinue to explore other outcomes as well.10 11
Recognising that the current inconsistency in outcome
reporting is a serious hindrance to progress in our spe-
cialty, 80 editors of Women’s Health journals have
formed a consortium to support the development, dis-
semination and implementation of core outcome sets.10
The Core Outcomes in Women’s and Newborn Health
(CROWN) initiative (http://www.crown-initiative.org)
will support the dissemination and implementation of a
core outcome set for endometriosis to increase the value
of an initial research effort and ensure all future endo-
metriosis trials report core outcomes and, therefore, rou-
tinely contribute data to important research questions.
Other specialties have succeeded in developing core
outcome sets. An international initiative has developed a
core outcome set for randomised trials evaluating inter-
ventions for chronic pain. The Initiative on Methods,
Measurement, and Pain Assessment in Clinical Trials
(IMMPACT) has developed a core outcome set including
six core outcome domains: (1) pain, (2) physical function-
ing, (3) emotional functioning, (4) participant ratings of
improvement and satisfaction with treatment, (5) symp-
toms and adverse events and (6) participant disposition.12
Objective
We aim to produce, disseminate and implement a core
outcome set for endometriosis.
METHODS AND ANALYSIS
Prospective registration
This study has been prospectively registered with the
Core Outcome Measures in Effectiveness Trials
(COMET) initiative, the registration number is 691 and
is available online (http://www.comet-initiative.org/
studies/details/691).
Steering group
An international steering group, including healthcare
professionals, researchers and women with endometri-
osis, has been formed to guide the development of this
core outcome set.
Scope of this core outcome set
The steering group has recommended the core
outcome set should apply to clinical studies evaluating
therapeutic interventions for women with endometriosis
and follow established core outcome set development
methodology (figure 1). All therapeutic interventions
for endometriosis will be considered regardless of type,
setting or mode of administration. We are not seeking to
reach consensus regarding the standardisation of study
design including other clinical, covariate and surgical
phenotype recording nor specimen collection, process-
ing and storage. The authors acknowledge the estab-
lished tools in these areas.5–8
Step 1: identifying potential outcomes
We performed a systematic review of randomised trials
evaluating therapeutic interventions for treatment of
endometriosis.3 We have extracted all outcomes and
outcome measures reported within the trial reports.
Working with patient and public representatives, we have
developed lay definitions for these outcomes. The out-
comes will be arranged into five domains: pain, subferti-
lity, quality of life, harm and resource utilisation which,
following the steering group’s agreement, will be
entered into a modified Delphi method.
Step 2: determining core outcomes
The core outcomes will be determined using a modified
Delphi method. The method consists of a series of con-
trolled rounds, where repeated surveys are adminis-
tered.13 The modified Delphi method facilitates
repeated reflection and rescoring. This promotes whole
and individual stakeholder group convergence on a con-
sensus of ‘core’ outcomes and has advantages over less
structured consensus methods. An online-modified
Delphi method allows for scoring without the influence
of dominant individuals or junior participants feeling
obliged to agree with more senior members. Web-based
Delphi surveys facilitate international participation and
are considered feasible, efficient and acceptable to the
user.13 14 The modified Delphi method will be delivered
within a web-based software hosted, designed and deliv-
ered by the University of Liverpool.
All key stakeholders will be invited to participate includ-
ing gynaecologists managing pain or subfertility asso-
ciated with endometriosis, chronic pain experts, health
psychologists, family physicians, researchers and women
with endometriosis. There are no clear recommendations
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for calculating the required sample size; based on previ-
ous studies, we will aim to include a minimum of 18 parti-
cipants from each stakeholder group.13
Delphi survey pilot
The Delphi survey will be developed to ensure the ease
of completion using appropriate terminology and phras-
ing. The Delphi survey will be piloted by the study com-
mittee and a sample of stakeholders before it is
accessible to all stakeholders.
Round 1
Participants will be asked to register online, provide
demographic details and commit to both rounds
(box 1). They will be allocated a unique identifier,
which will anonymise their responses. Outcomes will be
listed in five domains. Outcomes within each domain
will be listed alphabetically, and participants will be
asked to score individual outcomes using a nine-point
Likert Scale anchored between 1 (not important) to 9
(critical). This scale was created by the Grading of
Recommendations Assessment, Development and
Evaluation (GRADE) working group, and it has been
widely adopted by core outcome set developers.15
During the first round, participants will be invited to
suggest additional outcomes. The round will close fol-
lowing a 4-week window.
For each outcome, the median and IQR of scores will
be calculated and summarised graphically for the whole
and individual stakeholder group responses using
DelphiManager. Additional outcomes listed by partici-
pants will be reviewed by the steering committee and, if
novel, listed in round 2.
Round 2
Participants will be presented with individual stake-
holder group response and asked to reflect on the simi-
larities and differences observed before proceeding to
score each outcome again. Additional outcomes pro-
posed in round 1 of the Delphi survey will be added and
scored once without reflection. The round will close fol-
lowing a 4-week window.
For each outcome, the median and IQR of scores will
be summarised graphically by whole and individual
stakeholder group response. A standardised definition
of this round’s results will enable individual outcomes to
be classified:
1. Consensus in (classify as a core outcome): over 70% of
participants in each stakeholder group score this
outcome domain ‘critical’ AND <15% of participants
in each stakeholder group score outcome domain
‘not important’.
2. Consensus out (do not classify as a core outcome): over
70% of participants in each stakeholder group score
outcome domain ‘not important’ AND <15% of parti-
cipants in each stakeholder group score outcome
domain ‘critical’.
3. No consensus (do not classify as a core outcome): anything
else.13
Figure 1 Study outline. This
flow chart outlines the methods of
core outcome set formation.
Box 1 How do I contribute to improving endometriosis
research?
The authors acknowledge the expertise and commitment of this
journal’s readership to improving patient care. They warmly invite
readers to participate in the modified Delphi survey by registering
their interest to participate here: http://www.eepurl.com/bNCo81
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In the unlikely event that there are more than ten
core outcomes in a single domain the steering group
will be able to alter the threshold for classification of
consensus in. Round 2 results will be reviewed by the
steering group to consider whether there is a need for a
further Delphi survey round.
Step 3: stakeholder consultation
This final phase will involve a face-to-face meeting with
key stakeholders. The meeting will include a range of
views from participants that will be purposefully sampled
from those who have completed all rounds of the
Delphi study. The objective of the consensus meeting
will be to discuss no consensus outcomes and a final
core outcome set for endometriosis. A meeting is
planned where the results from each round of the
Delphi survey will be presented. To ensure unbiased
consensus formation among a group of varied partici-
pants, the steering committee will ensure that the
meeting is informal, inclusive, participatory and values
all opinions.14 To facilitate dissemination and implemen-
tation, we will invite editors from key journals, for
example the British Medical Journal, and funders of endo-
metriosis research.
Step 4: measuring core outcomes
Once core outcomes are agreed on, it will be important
to determine how the outcomes should be mea-
sured.16 17 Potential outcome measurement instruments
will be evaluated following a consensus-based guideline
for the selection of outcome measurement instruments
for outcomes included in a core outcome set.17 This
involves a four-step process for the identification of
outcome measurement instruments for an established
set of core outcomes: (1) conceptual considerations; (2)
finding existing outcome measurement instruments; (3)
quality assessment of outcome measurement instruments
and (4) generic recommendations for the selection of
outcome measurement instruments for a core outcome
set. This approach will ensure, for example, that all core
outcomes will still be included in the highly unlikely
event that all previous endometriosis studies failed to
include a particular core outcome measure.
High-quality outcome measures will be associated with
each core outcome. Where multiple high-quality instru-
ments exist, priority will be given to instruments used
within the WERF EPHect tools or core outcome mea-
sures for chronic pain clinical trials: IMMPACT recom-
mendations.4–8 12 If no high quality outcome




We asked the advice of the National Research Ethics
Service (NRES) about whether this study required
ethical review by an NHS Research Ethics Committee,
and they advised that this should be considered as
service evaluation and development (see online
supplementary appendix 1). All participants involved
will be asked for their consent before participation in
the Delphi study, and all procedures will be conducted
according to the Declaration of Helsinki.
Dissemination
Implementing and disseminating a core outcome set for
endometriosis in future clinical studies, systematic
reviews and clinical guidelines could make a profound
contribution to advancing the reach and relevance of
research to inform clinical practice, enhance patient
care and improve patient outcomes.
The selection of appropriate outcomes and outcome
measures in future clinical trials is critical. The develop-
ment of a core outcome set ensures that consensus out-
comes important to all stakeholders, including patients,
are routinely collected and reported. The Standard
Protocol Items Recommendations for Interventional
Trials (SPIRIT) statement recommends the use of core
outcome sets where they exist.18 An endorsement by
national and international funders, including National
Institutes of Health, will facilitate (and fund) the collec-
tion and reporting of core outcomes.
The CROWN initiative, supported by 80 specialty jour-
nals, including the Cochrane Gynaecology and Fertility
Group, has resolved to implement core outcome sets.
Participating journals will require authors to report the
results for core outcomes and offer conclusions based
on these outcomes rather than non-core or surrogate
outcomes.10
The production of high quantity and quality compar-
able data to be summarised within systematic reviews to
inform clinical practice guidelines would be an import-
ant step forward for guideline developers. The National
Institute of Clinical Excellence encourages the use of
core outcomes sets where available when selecting out-
comes during evidence scoping and synthesis. A core
outcome set for endometriosis could directly influence
national and international clinical practice.
CONCLUSION
The development of a core outcome set in endometri-
osis will enable the collection and reporting of a
minimum data set important to all stakeholders, includ-
ing women with endometriosis. Harmonising outcome
collection and reporting for future clinical trials, system-
atic reviews and clinical guidelines will make a profound
and important contribution to patient care.
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